Atlas Cup začína prvý profesionálny orbitálny šport na svete, úvodné preteky šampionátu sa uskutočnia na nízkej obežnej dráhe Zeme v roku 2028

SAN FRANCISCO, 27. januára 2026 /PRNewswire/ — Projekt Atlas Cup, ako prvý profesionálny šport, ktorý sa bude konať vo vesmíre, dnes oznamuje, že jeho úvodné majstrovstvá sa uskutočnia v roku 2028. Atlas Cup, založený koncom roka 2025, je popredný profesionálny športový mediálny projekt, v ktorom sa predstavujú bezpilotné kozmické lode súťažiace v najrýchlejšom športe v… Continue reading Atlas Cup začína prvý profesionálny orbitálny šport na svete, úvodné preteky šampionátu sa uskutočnia na nízkej obežnej dráhe Zeme v roku 2028

Компания Atlas Cup создает первый в мире профессиональный орбитальный спорт и организует первый чемпионат, который пройдет на низкой околоземной орбите в 2028 году

САН-ФРАНЦИСКО, 27 января 2026 г. /PRNewswire/ — Компания Atlas Cup, представляющая первый профессиональный вид спорта в космосе, сегодня объявляет о первом чемпионате, который состоится в 2028 году. Компания Atlas Cup, основанная в конце 2025 года, является первоклассным профессиональным спортивным медиа-холдингом, представляющим беспилотные космические летательные аппараты, соревнующиеся в самом быстром виде спорта в истории. Демонстрируя передовые космические… Continue reading Компания Atlas Cup создает первый в мире профессиональный орбитальный спорт и организует первый чемпионат, который пройдет на низкой околоземной орбите в 2028 году

Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma

SAN FRANCISCO and SUZHOU, China, Jan. 26, 2026 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic, and other major diseases, announced that its anti-GPRC5D/BCMA/CD3 tri-specific antibody IBI3003 has received Fast Track Designation (FTD) from the… Continue reading Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma

Nevada families explore education options during School Choice Week

RENO, Nev., Jan. 26, 2026 /PRNewswire/ — National School Choice Week begins today in Nevada and across the country, focusing on helping parents find the right K–12 schools for their children. Across the Silver State, more than 250 schools are taking part by hosting open houses, information sessions, parent nights, and other events. Gov. Joe… Continue reading Nevada families explore education options during School Choice Week

Georgia Power restores power to nearly all customers impacted by Winter Storm Fern

Service restored to 214,000+ customers as crews converge on hardest hit areas such as Clayton and Cornelia;Company’s generation fleet prepared to meet demand for electricity during severe cold this week ATLANTA, Jan. 26, 2026 /PRNewswire/ — Georgia Power has safely restored power to nearly all customers impacted by Winter Storm Fern. The multiday storm brought… Continue reading Georgia Power restores power to nearly all customers impacted by Winter Storm Fern

Bristow Group Announces Closing of $500 Million Senior Secured Notes Offering and Extension of ABL Facility

HOUSTON, Jan. 26, 2026 /PRNewswire/ — Bristow Group Inc. (NYSE: VTOL) (the “Company” or “Bristow”) announced today the closing of its private offering of $500 million aggregate principal amount of 6.750% senior secured notes due 2033 (the “notes”) and the amendment and extension of its asset-based revolving credit facility (the “ABL Facility”) until 2031. The… Continue reading Bristow Group Announces Closing of $500 Million Senior Secured Notes Offering and Extension of ABL Facility

Quiddity Engineering Opens Office in Waco

WACO, Texas, Jan. 26, 2026 /PRNewswire/ — Quiddity Engineering, an Engineering News-Record Top 500 Design Firm, has opened a new office in Waco, Texas, expanding its presence across the state. The opening of the Waco office reflects the firm’s commitment to steady, organic growth and its employee-owned culture, in which more than 700 employees have a… Continue reading Quiddity Engineering Opens Office in Waco

Greenberg Traurig’s Tricia A. Asaro Recognized on City & State’s ‘2026 Trailblazers in Healthcare’ List

ALBANY, N.Y., Jan. 26, 2026 /PRNewswire/ — Greenberg Traurig, LLP Shareholder Tricia A. Asaro was recognized on City & State’s “2026 Trailblazers in Healthcare” list. City & State notes Asaro is “a go-to expert for transactions involving managed care organizations, she’s known for guiding approvals tied to ownership changes and other consequential regulatory hurdles.” The list highlights key figures across New York’s… Continue reading Greenberg Traurig’s Tricia A. Asaro Recognized on City & State’s ‘2026 Trailblazers in Healthcare’ List

TE Connectivity announces pricing of $750 million senior notes offerings

GALWAY, Ireland, Jan. 26, 2026 /PRNewswire/ — TE Connectivity plc (NYSE: TEL) (“TE Connectivity”) today announced that Tyco Electronics Group S.A. (“TEGSA”), its indirect wholly-owned subsidiary, has priced an offering of: $200 million aggregate principal amount of its 4.500% senior notes due 2031 (the “additional 2031 notes”). $550 million aggregate principal amount of its 4.875%… Continue reading TE Connectivity announces pricing of $750 million senior notes offerings

AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm

NEW YORK, Jan. 26, 2026 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the “Class Period”), of the important March 2, 2026 lead plaintiff deadline in the securities class action first… Continue reading AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm